Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer

Inclusion Criteria: * diagnosed with stage I-IV ovarian, peritoneal or fallopian tube cancer * completed first-line taxane and platinum-based chemotherapy 1-4 months prior to being enrolled in the study (can be on bevacizumab maintenance) * in remission of their disease at the time of enrollment between 21 and 70 years of age * fluent in English * in the judgment of the consenting professional, have capacity to give consent Healthy Control Inclusion Criteria: * no diagnosis of cancer except basal cell carcinoma * between 21 and 70 years of age * fluent in English * has a mini-mental state exam (MMSE) score of 26 or higher * in the judgment of the consenting professional, have capacity to give consent Exclusion Criteria: * active or recurrent disease, or diagnosis of another cancer (except basal cell carcinoma) as per medical records at the time of enrollment * exposure to chemotherapy or radiation therapy for any medical condition unrelated to ovarian cancer * on hormonal therapy at the time of enrollment * neurological disorder or moderate to severe head trauma (loss of consciousness \> 60 min) * neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, etc. * self-reported Axis I psychiatric disorder (DSM-IV), major affective disorder (untreated), bipolar disorder, schizophrenia * unable to complete cognitive tests * with standard contraindications to MRI examinations Healthy Control Exclusion Criteria: * exposure to chemotherapy or radiation therapy for any medical condition * on hormone replacement therapy at the time of enrollment * neurological disorder or moderate to severe head trauma (loss of consciousness \> 60 min) * neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, etc.